DNA binding of the anti-cancer platinum complex trans-[(Pt(NH3)2Cl)2μ-dpzm]2+

Journal of the Chemical Society. Dalton Transactions

Volumn 3, Issue 18, 2003, Pages 3486-3492

  Wheate, Nial J ^a,b   Evison, Ben J ^c   Herlt, Anthony J ^d   Phillips, Don R ^c   Collins, J Grant ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b Joint Health Support Agency   (Australia)

^c LA TROBE UNIVERSITY   (Australia)

^d AUSTRALIAN NATIONAL UNIVERSITY   (Australia)

Author keywords

Bioinorganic chemistry; Kinetics; Nmr spectroscopy; Nucleobases; Platinum

Indexed keywords

BIOASSAY; CHEMICAL BONDS; COMPLEXATION; DNA; DRUG PRODUCTS; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; ONCOLOGY; PLATINUM COMPOUNDS;

ANTI-CANCER AGENTS;

ORGANOMETALLICS;

EID: 0141921868     PISSN: 14779226     EISSN: None     Source Type: Journal    
DOI: 10.1039/b306417d     Document Type: Article

References (29)

1. E. Wong, C.M. Giandomenico: Chem. Rev. (1999), 99: 2451.
2. N. Farrell, in Platinum-based Drugs in Cancer Therapy, ed. L.R. Kelland and N.P. Farrell, Humana Press, Totowa, NJ, (2000), pp. 321–338.
3. N.J. Wheate, J.G. Collins: Coord. Chem. Rev. (2003), 241: 133.
4. E.R. Jamieson, S.J. Lippard: Chem. Rev. (1999), 99: 2467.
5. N.J. Wheate, J.G. Collins: J. Inorg. Biochem. (2000), 78: 313.
6. N.J. Wheate, L.K. Webster, C.R. Brodie, J.G. Collins: Anti-cancer Drug Des. (2000), 15: 313.
7. J.W. Cox, S.J. Berners-Price, M.S. Davies, Y. Qu, N. Farrell: J. Am. Chem. Soc. (2001), 123: 1316.
8. N.J. Wheate, S.M. Cutts, D.R. Phillips, J.R. Aldrich-Wright, J.G. Collins: J. Inorg. Biochem. (2001), 84: 119.
9. Y. Qu, N.J. Scarsdale, M.-Y. Tran, N.P. Farrell: J. Biol. Inorg. Chem. (2003), 8: 19.
10. N.J. Wheate, C. Cullinane, L.K. Webster, J.G. Collins: Anti-cancer Drug Des. (2001), 16: 91.
11. V. Brabec, J. Kasparkova, O. Vrana, O. Novakova, J.W. Cox, Y. Qu, N. Farrell: Biochemistry (1999), 38: 6781.
12. S.K. Miller, L.G. Marzilli: Inorg. Chem. (1985), 24: 2421.
13. G.M. Clore, A.M. Gronenborn: J. Am. Chem. Soc. (1982), 104: 1369.
14. Y. Qu, N. Farrell: J. Am. Chem. Soc. (1991), 113: 4851.
15. R.M. Scheek, R. Boelens, N. Russo, J.H. van Boom, R. Kaptein: Biochemistry (1984), 23: 1371-1376.
16. J. Feigon, W. Leupin, W.A. Denny, D.R. Kearns: Biochemistry (1983), 22: 5943.
17. D.J. Patel, L. Shapiro, D. Hare: J. Biol. Chem. (1986), 261: 1223.
18. H. Huang, L. Zhu, B.R. Reid, G.P. Drobny, P.B. Hopkins: Science (1995), 270: 1842.
19. D. Yang, S.S.G.E. van Boom, J. Reedijk, J.H. van Boom, N. Farrell, A.H-J. Wang: Nat. Struct. Biol. (1995), 2: 577.
20. K. Wuthrich, in NMR of Proteins and Nucleic Acids, John Wiley and Sons, New York, (1986).
21. P.D. Prenzler, W.D. McFadyen: J. Inorg. Biochem. (1997), 68: 279.
22. C. Cullinane, G. Wickham, W.D. McFadyen, W.A. Denny, B.D. Palmer, D.R. Phillips: Nucleic Acids Res. (1993), 21: 393.
23. L.C. Perrin, C. Cullinane, W.D. McFadyen, D.R. Phillips: Anti-cancer Drug Des. (1999), 14: 243.
24. L.R. Ferguson, A.P. Liu, W.A. Denny, C. Cullinane, T. Talarico, D.R. Phillips: Chem. Biol. Interact. (2000), 126: 15.
25. S. Trofimenko: Chem. Rev. (1972), 72: 497.
26. P. Fantucci, V. Valenti: J. Chem. Soc., Dalton Trans (1992), 1981.
27. N.J. Wheate, J.A. Broomhead, J.G. Collins, A.I. Day: Aust. J. Chem. (2001), 54: 141.
28. M. Piotto, V. Saudek, V. Sklenar: J. Biomol. NMR (1992), 2: 661.
29. T.W. Hambley and V. Munk, personal communication.